These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36363801)

  • 21. Increased risk of developing peripheral neuropathy in patients coinfected with HIV-1 and HTLV-2.
    Zehender G; Colasante C; Santambrogio S; De Maddalena C; Massetto B; Cavalli B; Jacchetti G; Fasan M; Adorni F; Osio M; Moroni M; Galli M
    J Acquir Immune Defic Syndr; 2002 Dec; 31(4):440-7. PubMed ID: 12447016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune Compromise in HIV-1/HTLV-1 Coinfection With Paradoxical Resolution of CD4 Lymphocytosis During Antiretroviral Therapy: A Case Report.
    Rockwood N; Cook L; Kagdi H; Basnayake S; Bangham CRM; Pozniak AL; Taylor GP
    Medicine (Baltimore); 2015 Dec; 94(50):e2275. PubMed ID: 26683952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Onset of opportunistic infections in patients co-infected by HTLV-1 and HIV-1, with high CD4+ cells count.
    Regis C; Oliveira A; Brites C
    Braz J Infect Dis; 2009 Aug; 13(4):311-3. PubMed ID: 20231997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4 counts and viral loads of newly diagnosed HIV-infected individuals: implications for treatment as prevention.
    Govender S; Otwombe K; Essien T; Panchia R; de Bruyn G; Mohapi L; Gray G; Martinson N
    PLoS One; 2014; 9(3):e90754. PubMed ID: 24595317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The reasons to include the serology of human T-lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in the clinical follow-up of patients with viral hepatitis B and C in Brazil.
    Campos KR; Alves FA; Lemos MF; Moreira RC; Marcusso RMN; Caterino-de-Araujo A
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008245. PubMed ID: 32453768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coinfection with HTLV-I and HIV: increase in HTLV-I-related outcomes but not accelerated HIV disease progression?
    Harrison LH; Schechter M
    AIDS Patient Care STDS; 1998 Aug; 12(8):619-23. PubMed ID: 15468433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD4+ T Cell Recovery and Hepatitis B Virus Coinfection in HIV-Infected Patients from Côte d'Ivoire Initiating Antiretroviral Therapy.
    Houghtaling L; Moh R; Abdou Chekaraou M; Gabillard D; Anglaret X; Eholié SP; Zoulim F; Danel C; Lacombe K; Boyd A
    AIDS Res Hum Retroviruses; 2018 May; 34(5):439-445. PubMed ID: 29466862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transient increment of HTLV-2 proviral load in HIV-1-co-infected patients during treatment intensification with raltegravir.
    Abad-Fernández M; Cabrera C; García E; Vallejo A
    J Clin Virol; 2014 Mar; 59(3):204-7. PubMed ID: 24457115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myelopathy among Brazilians coinfected with human T-cell lymphotropic virus type I and HIV.
    Harrison LH; Vaz B; Taveira DM; Quinn TC; Gibbs CJ; de Souza SH; McArthur JC; Schechter M
    Neurology; 1997 Jan; 48(1):13-8. PubMed ID: 9008486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus Coinfection.
    Nicolás D; Esteve A; Cuadros A; Campbell CNJ; Tural C; Podzamczer D; Murillas J; Homar F; Segura F; Force L; Vilaró J; Masabeu À; Garcia I; Mercadal J; Montoliu A; Ferrer E; Riera M; Cifuentes C; Ambrosioni J; Navarro G; Manzardo C; Clotet B; Gatell JM; Casabona J; Miró JM; ; Murillas J; Manzardo C; Masabeu A; Mercadal J; Cifuentes C; Dalmau D; Domingo P; Falcó V; Curran A; Agustí C; Montoliu A; Pérez I; Curto J; Gargoulas F; Gómez A; Rubia JC; Zamora L; Blanco JL; Garcia-Alcaide F; Martínez E; Mallolas J; Llibre JM; Sirera G; Romeu J; Jou A; Negredo E; Saumoy M; Imaz A; Bolao F; Cabellos C; Peña C; DiYacovo S; Van Den Eynde E; Sala M; Cervantes M; Amengual MJ; Navarro M; Segura V; Barrufet P; Molina J; Alvaro M; Payeras T; Gracia Mateo M; Fernández J
    Clin Infect Dis; 2016 Jun; 62(12):1578-1585. PubMed ID: 27126346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence and effect of HBV and HCV co-infections on the immuno-virologic responses of adult HIV-infected persons on anti-retroviral therapy.
    Annison L; Hackman H; Eshun PF; Annison S; Forson P; Antwi-Baffour S
    PLoS One; 2022; 17(11):e0278037. PubMed ID: 36417469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current scenario of opportunistic and co-infections in HIV-infected individuals at a tertiary care hospital in Mumbai, India.
    Chavan VR; Chaudhary V; Ahir P; Mehta R; Mavani PS; Kerkar C; Pramanik JM
    Indian J Med Microbiol; 2015; 33(1):78-83. PubMed ID: 25560006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human T cell lymphotropic virus type I does not increase human immunodeficiency virus viral load in vivo.
    Harrison LH; Quinn TC; Schechter M
    J Infect Dis; 1997 Feb; 175(2):438-40. PubMed ID: 9203667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of CD4+ blood cell count and HIV viral load on treatment response with direct acting antivirals in HIV and HCV coinfected patients: insights from the German Hepatitis C-Registry.
    Bischoff J; Mauss S; Cordes C; Lutz T; Scholten S; Cornberg M; Manns MP; Baumgarten A; Rockstroh JK
    HIV Clin Trials; 2018 Dec; 19(6):225-234. PubMed ID: 30890063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection.
    Beilke MA; Traina-Dorge VL; Sirois M; Bhuiyan A; Murphy EL; Walls JM; Fagan R; Winsor EL; Kissinger PJ
    Clin Infect Dis; 2007 May; 44(9):1229-34. PubMed ID: 17407044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C viral load in HCV-monoinfected and HCV/HIV-1-, HCV/HTLV-1/-2-, and HCV/HIV/HTLV-1/-2-co-infected patients from São Paulo, Brazil.
    Alves FA; Campos KR; Lemos MF; Moreira RC; Caterino-de-Araujo A
    Braz J Infect Dis; 2018; 22(2):123-128. PubMed ID: 29625021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS.
    Turci M; Pilotti E; Ronzi P; Magnani G; Boschini A; Parisi SG; Zipeto D; Lisa A; Casoli C; Bertazzoni U
    J Acquir Immune Defic Syndr; 2006 Jan; 41(1):100-6. PubMed ID: 16340481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and risk factor analysis for HIV/HTLV 1/2 coinfection in Paraíba state, Brazil.
    Santos de Souza M; Prado Gonçales J; Santos deMorais VM; Silva Júnior JVJ; Lopes TRR; Costa JEFD; Côelho MRCD
    J Infect Dev Ctries; 2021 Oct; 15(10):1551-1554. PubMed ID: 34780380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
    Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I
    AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of human T-cell lymphotropic virus I infection on clinical and immunologic outcomes in patients coinfected with HIV and hepatitis C virus.
    Bahia F; Novais V; Evans J; Le Marchand C; Netto E; Page K; Brites C
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 3(0 3):S202-7. PubMed ID: 21857319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.